SECTORAL ASSET MANAGEMENT INC
CIK: 0001274413Latest portfolio: $124.8M · Q4 2025
Holdings
74
Total Value
$124.8M
New Positions
6
Closed Positions
14
Top Holdings
View All 74 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | EVMNEVOMMUNE INC | 589,005 | $10.1M | 8.08% | NEW | |
| 2 | CTNMCONTINEUM THERAPEUTICS | 800,787 | $9.2M | 7.34% | — | |
| 3 | LLYELI LILLY & CO | 7,276 | $7.8M | 6.27% | -2,100 | |
| 4 | SISHOULDER INNOVATIONS | 492,435 | $7.0M | 5.64% | +62K | |
| 5 | UNHUNITEDHEALTH GRP INC | 13,595 | $4.5M | 3.60% | +50 | |
| 6 | AMGNAMGEN INC | 13,070 | $4.3M | 3.43% | +3K | |
| 7 | JNJJOHNSON & JOHNSON | 20,300 | $4.2M | 3.37% | +5K | |
| 8 | ABBVABBVIE INC | 16,800 | $3.8M | 3.08% | +2K | |
| 9 | VRTXVERTEX PHARMA | 8,005 | $3.6M | 2.91% | +290 | |
| 10 | ABTABBOTT LABS | 23,498 | $2.9M | 2.36% | +6K | |
| 11 | REGNREGENERON PHARMCTCLS | 3,715 | $2.9M | 2.30% | -253 | |
| 12 | ISRGINTUITIVE SURGIC INC | 4,850 | $2.7M | 2.20% | -900 | |
| 13 | BSXBOSTON SCIENTIFIC | 27,626 | $2.6M | 2.11% | +6K | |
| 14 | ARGXARGENX SE SPN ADR | 2,894 | $2.4M | 1.95% | -996 | |
| 15 | DHRDANAHER CORP | 10,575 | $2.4M | 1.94% | — | |
| 16 | SYKSTRYKER CORP | 6,550 | $2.3M | 1.85% | +2K | |
| 17 | TMOTHERMO FISHER SCIENTIFIC | 3,900 | $2.3M | 1.81% | — | |
| 18 | MRKMERCK & CO INC | 21,400 | $2.3M | 1.81% | +5K | |
| 19 | GILDGILEAD SCIENCES INC | 17,885 | $2.2M | 1.76% | -1,665 | |
| 20 | IM8NINSMED INC | 11,182 | $1.9M | 1.56% | -2,243 | |
| 21 | DC4DEXCOM INC | 28,700 | $1.9M | 1.53% | +8K | |
| 22 | VERAVERA THERAPEUTICS | 36,858 | $1.9M | 1.50% | +7K | |
| 23 | GPCRSTRUCTURE THERAPEUTICS | 23,872 | $1.7M | 1.33% | -198,000 | |
| 24 | BNTXBIONTECH SE | 17,218 | $1.6M | 1.31% | -442 | |
| 25 | EWEDWARDS LIFESCIENCE | 17,250 | $1.5M | 1.18% | +2K |
Quarterly Changes
Sector Breakdown
Healthcare0.0% ($1.0083915278197042e+231T)
Unknown0.0% ($19461904.8T)
Filing History
Fund Information
SECTORAL ASSET MANAGEMENT INC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $124.8M across 74 holdings. The largest position is EVOMMUNE INC (EVMN), representing 8.1% of the portfolio. Compared to the previous quarter, the fund opened 6 new positions and closed 14 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.